
    
      Two sequence study where Lu AG06466 will be dosed with and without food, Sequence 1 and
      Sequence 2. Each subject will receive single oral doses of Lu AG06466. Subject will be
      randomized to one of two sequences.

      For inhibition of CYP3A4, each subject will receive a once daily dosage of itraconazole from
      Day 5 to Day 11.
    
  